Biopulse is an Italian company mainly engaged in the medical transnational research sector. The founders of the company, Dr. Enrico Pierluigi Spugnini and Dr. Alfonso Baldi, are internationally considered to be among the leading experts in veterinary electrochemotherapy ECT  and electrogenetherapy EGT, and have widely published in international medical and veterinarian journals.

Biopulse operates in the Biotechnology sector, and his main mission is the invention, the design, the manufacture and the marketing of innovative electromedical and electrotherapeutic instruments. Biopulse has now fully completed the phase of design, construction and industrialization of an electroporation device for veterinary use: Onkodisruptor ®. The device is entirely designed and manufactured in Italy with the highest quality standards.